COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,541 Articles (22,881 medRxiv, 8,660 bioRxiv)

Most recent first Previous |  Page 1422: Articles 14211-14220  | Next

Durable Humoral and Cellular Immune Responses Following Ad26.COV2.S Vaccination for COVID-19
Barouch, D. H., Stephenson, K., Sadoff, J., Yu, J., Chang, A., Gebre, M., McMahan, K., Liu, J., Chandrashekar, A., Patel, S., Le Gars, M., de Groot, A., Heerwegh, D., Struyf, F., Douoguih, M., van Hoof, J., Schuitemaker, H.
10.1101/2021.07.05.21259918 — Posted: 2021-07-07 Discussion: Onsite
Critical Role of the Subways in the Initial Spread of SARS-CoV-2 in New York City
Harris, J. E.
10.1101/2021.07.03.21259973 — Posted: 2021-07-07
Anaesthetic Higher Specialty Training Recruitment in the United Kingdom During the COVID-19 Pandemic: A National Survey
Durrant, F., Edwardson, S., El-Ghazali, S., Holt, C., McCrossan, R., Pramanik, I., Subramaniam, J., Wong, D. J. N.
10.1101/2021.07.03.21259616 — Posted: 2021-07-07 Discussion: Onsite
SARS-CoV-2 IgG detection in human oral fluids
Hoschler, K., Ijaz, S., Andrews, N., Ho, S., Dicks, S., Jegatheesan, K., Poh, J., Warrener, L., Kankeyan, T., Baawuah, F., Beckmann, J., Okike, I. O., Ahmad, S., Garstang, J., Brent, A. J., Brent, B., Aiano, F., Brown, K. E., Ramsay, M. E., Brown, D. W., Parry, J. V., Ladhani, S. N., Zambon, M.
10.1101/2021.07.07.21260121 — Posted: 2021-07-07
Anticoagulants and Antiplatelets in COVID-19: Impact on Survival and Thromboembolism Development
Salmon, T., Titley, M., Noori, Z., Crosby, M., Sankaranarayanan, R.
10.1101/2021.07.03.21254541 — Posted: 2021-07-07
High resolution linear epitope mapping of the receptor binding domain of SARS-CoV-2 spike protein in COVID-19 mRNA vaccine recipients.
Nitahara, Y., Nakagama, Y., Kaku, N., Candray, K., Michimuko, Y., Tshibangu-Kabamba, E., Kaneko, A., Yamamoto, H., Mizobata, Y., Kakeya, H., Yasugi, M., Kido, Y.
10.1101/2021.07.03.21259953 — Posted: 2021-07-07
Preserved C-reactive protein responses to blood stream infections following tocilizumab treatment for COVID-19
Wey, E. Q., Bristow, C., Nandani, A., O'Farrell, B., Pang, J., Lanzman, M., Yang, S., Ho, S., Mack, D., Spiro, M., Balakrishnan, I., Bhagani, S., Pollara, G.
10.1101/2021.07.03.21259949 — Posted: 2021-07-07
Efficacy of remdesivir-containing therapy in hospitalized COVID-19 patients: a prospective clinical experience
Russo, A., Binetti, E., Borrazzo, C., Gentilini Cacciola, E., Battistini, L., Ceccarelli, G., Mastroianni, C. M., d'Ettorre, G.
10.1101/2021.07.01.21259852 — Posted: 2021-07-07
Genomic surveillance reveals the spread patterns of SARS-CoV-2 in coastal Kenya during the first two waves
Agoti, C. N., Ochola-Oyier, L. I., Mohammed, K. S., Lambisia, A. W., de Laurent, Z. R., Morobe, J. M., Mburu, M. W., Omuoyo, D. O., Ongera, E. M., Ndwiga, L., Maitha, E., Kitole, B., Suleiman, T., Mwakinangu, M., Nyambu, J., Otieno, J., Salim, B., Musyoki, J., Murunga, N., Otieno, E., Kiiru, J., Kasera, K., Amoth, P., Mwangangi, M., Aman, R., Kinyanjui, S., Warimwe, G., Phan, M., Agweyu, A., Cotten, M., Barasa, E., Tsofa, B., Nokes, D. J., Bejon, P., Githinji, G.
10.1101/2021.07.01.21259583 — Posted: 2021-07-07
Tocilizumab and sarilumab alone or in combination with corticosteroids for COVID-19: A systematic review and network meta-analysis
Zeraatkar, D., Cusano, E., Diaz Martinez, J. P., Qasim, A., Mangala, S. O., Kum, E., Bartoszko, J. J., Devji, T., Agoritsas, T., Lamontagne, F., Rochwerg, B., Vandvik, P. O., Brignardello-Petersen, R., Siemieniuk, R.
10.1101/2021.07.05.21259867 — Posted: 2021-07-07

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).